Huge Oracle Insider Sale: Catz Unloads 3.7 M Shares for $793 M
Rhea-AI Filing Summary
Oracle (NYSE:ORCL) filed a Form 4 disclosing CEO Safra Catz’s cashless option exercises and same-day sales on 25-26 Jun 2025.
- Options exercised: 3.74 M shares at $51.13; 5 M new performance-based options granted 24 Jun 2025.
- Shares sold: 3.74 M shares at weighted-average prices of $210.64-$215.44, realising ≈$793 M.
- Post-transaction ownership: 1,118,592 directly-held shares (unchanged) plus 1.26 M unexercised options.
The sizeable monetisation, though executed under a Rule 10b5-1 plan, may influence investor sentiment and raises governance questions about pay design.
Positive
- Performance goal achieved, triggering vesting of 5 M CEO options and signalling attainment of board-approved targets
Negative
- CEO Safra Catz sold ~3.74 M shares worth ≈$793 M, potentially signalling reduced forward conviction and increasing short-term share supply
Insights
TL;DR: CEO liquidates $793 M; optics negative, alignment unchanged.
Safra Catz converted 3.74 M deep-in-the-money options into cash, selling the entire allotment within two days. Despite the 10b5-1 shield, such a one-shot, high-value disposal often draws scrutiny over executive confidence and compensation structures. Her direct share count stays at 1.118 M, but she has exchanged upside potential for immediate liquidity. The filing also exposes the generous spread between strike and market price, highlighting the board’s pay practices. Overall governance optics skew negative.
TL;DR: Large sale adds near-term supply; fundamentals intact.
The transaction neither dilutes Oracle nor affects diluted EPS, yet 3.7 M shares—about 45 % of a typical week’s volume—hit the tape, which can pressure the stock technically. Option vesting confirms performance targets were met, an incremental positive, but the sheer cash realisation by the CEO may temper sentiment. Longer-term valuation drivers remain unchanged, so impact is more tactical than structural.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option | 1,865,701 | $0.00 | -- |
| Exercise | Common Stock | 1,865,701 | $51.13 | $95.39M |
| Sale | Common Stock | 243,112 | $210.9257 | $51.28M |
| Sale | Common Stock | 244,280 | $211.9571 | $51.78M |
| Sale | Common Stock | 899,234 | $212.9024 | $191.45M |
| Sale | Common Stock | 479,075 | $213.6356 | $102.35M |
| Exercise | Stock Option | 1,873,791 | $0.00 | -- |
| Exercise | Common Stock | 1,873,791 | $51.13 | $95.81M |
| Sale | Common Stock | 706,221 | $210.6448 | $148.76M |
| Sale | Common Stock | 265,114 | $211.8392 | $56.16M |
| Sale | Common Stock | 308,140 | $212.6872 | $65.54M |
| Sale | Common Stock | 308,116 | $213.7685 | $65.87M |
| Sale | Common Stock | 263,463 | $214.6744 | $56.56M |
| Sale | Common Stock | 22,637 | $215.4426 | $4.88M |
| Sale | Common Stock | 100 | $216.815 | $22K |
| Grant/Award | Stock Option | 5,000,000 | $0.00 | -- |
Footnotes (1)
- Sale of shares pursuant to Rule 10b5-1 Plan adopted on September 25, 2024. This transaction was executed in multiple trades at prices ranging from $210.22 to $211.215. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $211.22 to $212.215. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $212.22 to $213.215. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $213.22 to $214.215. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $214.22 to $215.215. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $215.22 to $215.93. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $210.39 to $211.385. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $211.395 to $212.39. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $212.395 to $213.39. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $213.395 to $214.385. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected. Represents 2/7 of the number of shares subject to a performance-based option that vested upon certification of a performance goal by the Compensation Committee.
FAQ
What proceeds did the ORCL CEO realise from the sale?
At what price were Safra Catz’s options exercised?
What is Safra Catz’s remaining direct ownership in ORCL after the transactions?
What triggered the vesting of the 5 million new options granted to the CEO?